Kura Oncology, Inc. (KURA)
9.35
+0.27
(+2.97%)
USD |
NASDAQ |
Oct 19, 15:33
Kura Oncology Cash from Operations (Annual) : -64.06M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -64.06M |
| December 31, 2024 | 134.32M |
| December 31, 2023 | -124.82M |
| December 31, 2022 | -110.06M |
| December 31, 2021 | -104.55M |
| December 31, 2020 | -69.83M |
| Date | Value |
|---|---|
| December 31, 2019 | -54.76M |
| December 31, 2018 | -48.66M |
| December 31, 2017 | -28.44M |
| December 31, 2016 | -25.35M |
| December 31, 2015 | -17.92M |
| December 31, 2014 | -0.8492M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Inovio Pharmaceuticals, Inc. | -88.63M |
| Fortress Biotech, Inc. | -71.34M |
| Spero Therapeutics, Inc. | -12.62M |
| Gossamer Bio, Inc. | -171.27M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |